F Härtig1, J Purrucker2, C Hametner2, S Poli3. 1. Abteilung Neurologie mit Schwerpunkt neurovaskuläre Erkrankungen, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72070, Tübingen, Deutschland. 2. Neurologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. 3. Abteilung Neurologie mit Schwerpunkt neurovaskuläre Erkrankungen, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72070, Tübingen, Deutschland. sven.poli@uni-tuebingen.de.
Abstract
BACKGROUND: During the last two decades major efforts in clinical research have led to the establishment of intravenous thrombolysis as the first line acute therapy for ischemic stroke. More recently, data from successful phase III trials have provided proof of the efficiency of mechanical recanalization in acute stroke. The fact that the efficiency of the available therapies can be increased through faster delivery is well documented; however, many institutions dealing with the emergency care of stroke patients lack organizational or infrastructural arrangements to optimize time efficiency in the diagnostic and therapeutic workup. CONCLUSION: Many of these arrangements have been well evaluated, can be implemented at reasonable costs and have been proven to increase the beneficial effects of thrombolytic therapy.
BACKGROUND: During the last two decades major efforts in clinical research have led to the establishment of intravenous thrombolysis as the first line acute therapy for ischemic stroke. More recently, data from successful phase III trials have provided proof of the efficiency of mechanical recanalization in acute stroke. The fact that the efficiency of the available therapies can be increased through faster delivery is well documented; however, many institutions dealing with the emergency care of strokepatients lack organizational or infrastructural arrangements to optimize time efficiency in the diagnostic and therapeutic workup. CONCLUSION: Many of these arrangements have been well evaluated, can be implemented at reasonable costs and have been proven to increase the beneficial effects of thrombolytic therapy.
Entities:
Keywords:
Door-to-needle time; Stroke unit; Thrombectomy; Thrombolytic therapy; Time management
Authors: David L Tirschwell; W T Longstreth; Kyra J Becker; Richard E Gammans; LuAnn A Sabounjian; Scott Hamilton; Lewis B Morgenstern Journal: Stroke Date: 2002-12 Impact factor: 7.914
Authors: Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Martin Ebinger; Benjamin Winter; Matthias Wendt; Joachim E Weber; Carolin Waldschmidt; Michal Rozanski; Alexander Kunz; Peter Koch; Philipp A Kellner; Daniel Gierhake; Kersten Villringer; Jochen B Fiebach; Ulrike Grittner; Andreas Hartmann; Bruno-Marcel Mackert; Matthias Endres; Heinrich J Audebert Journal: JAMA Date: 2014 Apr 23-30 Impact factor: 56.272
Authors: C Leiva-Salinas; A Aghaebrahim; G Zhu; J T Patrie; W Xin; B C Lau; T Jovin; M Wintermark Journal: Neuroradiology Date: 2013-04-05 Impact factor: 2.804
Authors: Atte Meretoja; Mahsa Keshtkaran; Jeffrey L Saver; Turgut Tatlisumak; Mark W Parsons; Markku Kaste; Stephen M Davis; Geoffrey A Donnan; Leonid Churilov Journal: Stroke Date: 2014-03-13 Impact factor: 7.914
Authors: Bijen Nazliel; Sidney Starkman; David S Liebeskind; Bruce Ovbiagele; Doojin Kim; Nerses Sanossian; Latisha Ali; Brian Buck; Pablo Villablanca; Fernando Vinuela; Gary Duckwiler; Reza Jahan; Jeffrey L Saver Journal: Stroke Date: 2008-06-12 Impact factor: 7.914
Authors: Atte Meretoja; Louise Weir; Melissa Ugalde; Nawaf Yassi; Bernard Yan; Peter Hand; Melinda Truesdale; Stephen M Davis; Bruce C V Campbell Journal: Neurology Date: 2013-08-14 Impact factor: 9.910